Longevity biotech is now a market. The Longevity Biotech Report 2026 tracks 3,036 assets across 781 companies and projects a $617BN annual market by 2045. Read it here: Sponsored by MuseCell Innovations: #LongevityBiotech#

Fortum is seeking Swedish state aid for a new 1.2–3.4 GW nuclear plant at Oskarshamn. Sweden wants two new reactors by 2035 and 10 by 2045, backed by state loans and power-price guarantees. #NuclearEnergy# #Sweden# #EnergySecurity#

Thailand, New Zealand to Upgrade Ties During Anutin Visit Thailand and New Zealand are expected to elevate relations to a strategic partnership during Prime Minister Anutin Charnvirakul’s official visit from August 20–22, the first by a Thai prime minister in 13 years. Anutin will travel with executives from more than 10 Thai companies to explore trade and investment opportunities. Both countries aim to triple bilateral trade by 2045 and increase the use of their existing economic partnership agreement. The planned upgrade was discussed when newly appointed New Zealand Ambassador Raylene Siale Tagaloa Liufalani paid an introductory courtesy call on Anutin at Government House on Thursday. Appointed in December 2025, she assumed her post this year after previously serving as ambassador to Argentina, with concurrent accreditation to Paraguay and Uruguay. The two sides also identified technology, education and tourism as areas for expanded cooperation as they mark 70 years of diplomatic relations. #Thailand# #NewZealand#

Christopher Duntsch was a neurosurgeon who operated in the Dallas and Fort Worth area of Texas between 2011 and 2013. In under two years, 33 of his 38 patients were harmed, two of them fatally. Others were left paralyzed or in permanent pain. Colleagues who watched him work described basic errors: operating on the wrong part of the spine, cutting nerves, placing hardware into soft tissue. Hospitals suspended him or let him resign quietly rather than fight him, and he moved on to the next one without the failures following him. One of his last operations, in 2012, was a spinal fusion on Mary Efurd, an elderly patient. He operated at the wrong level, severed a nerve root, and left hardware loose in her muscle. She was left unable to walk. The Texas Medical Board suspended his license in June 2013 and revoked it that December. Prosecutors charged him in 2015, arguing that the pattern of harm showed intent rather than incompetence. In February 2017, a jury convicted him of injury to an elderly person, and he was sentenced to life in prison. His appeals were rejected in 2018 and 2019. He becomes eligible for parole in 2045. The creepiest photos ever taken:

I'm a cardiologist. For 25 years I've been trained to be brilliant at the worst moment of your life. The 3am cath lab. The stent threaded into a closing artery. The bypass. The shock that restarts a heart that had already quit. I've stood in those rooms more times than I can count, and I will never stop being in awe of what we can do there. But I need to tell you the quiet secret of my entire field: By the time you meet me in that room, the disease has already won most of the war. We are firefighters who show up after the house is halfway gone. We've built the most sophisticated rescue system in the history of medicine — and aimed almost none of it at stopping the fire from starting. 800,000 Americans still have a heart attack every year. A staggering share of them were preventable — not weeks earlier, but years earlier. We just had no way to see it coming. That is now changing, and the shift is so profound that ACC President @Drroxmehran and @EricTopol just laid it out as a once-in-a-generation turning point for medicine — a call to move cardiology from reacting to disease to predicting and preventing it before it ever declares itself. Here is what almost no one outside my field understands yet. Point by point. We've been staring at the wrong thing for decades. Old cardiology was obsessed with the narrowing — how clogged is the pipe on the angiogram. But here's the twist that still surprises even doctors: most heart attacks don't come from the tight, obvious blockage. They come from softer, "invisible" plaque that isn't blocking much of anything — until the day it ruptures without warning. We were reading the visible enemy and missing the one that actually kills. The real villains are inflamed, unstable plaque and the fire smoldering in the artery wall. We can now see that hidden fire. AI-powered CT scans of the heart can detect the dangerous features older imaging missed — the composition of a plaque, and the inflammation glowing in the fat around the vessel, years before anything ruptures. We are no longer guessing which plaque is a ticking clock. We're starting to read the clock directly. Your DNA can flag the danger before you have a single symptom. Polygenic risk scores add up thousands of tiny genetic variants into one number. They can identify people carrying 2 to 7 times the lifetime risk — people with normal cholesterol, no family history, no warning signs at all. A young, "healthy" 30-year-old could be walking around with a hidden inheritance we can finally catch and act on decades early. A photograph of your eye can predict your heart. This is the one that stops people cold. Deep-learning models can look at an ordinary retinal photo — the kind snapped at the optometrist — and estimate your biological age and your future heart-attack risk. The back of your eye is the only place in the entire body where we can see living blood vessels with the naked eye. It turns out they've been narrating your cardiovascular story the whole time, and we finally learned to read the language. And now the machines that tie it all together. Multimodal AI can fuse your genetics, your imaging, your medical record, and the data streaming off your watch into a single forecast of where your heart is headed — a living risk trajectory that updates in real time. Pair that with a new generation of drugs that crush the most dangerous cholesterol particles, cool inflammation, and protect the heart independent of weight — and primary prevention becomes something we've never had before: precise. Put all five together and something historic becomes possible: We can identify the person who is going to have a heart attack in 2045 — today. And we can rewrite that ending. Here's why this matters more than almost anything else in medicine. Of the great age-related killers — cancer, dementia, heart disease — heart disease is the most preventable. We already have the lifestyle levers. We already have medications that work. Statins alone cut the risk of a major cardiac event by roughly 20–25% for each substantial drop in LDL, and we've held that power for years. What we lacked was knowing exactly who to protect, and when to begin. Now we're being handed the map. Picture it: a routine checkup — or even an eye exam — quietly generating a risk profile that says this person needs us now, not in thirty years. That is not science fiction. Every single piece already exists and is maturing fast. I became a cardiologist to save lives. And I'm realizing the most powerful version of that was never the dramatic rescue at midnight. It's the heart attack that never happens. The room you never end up in. The ordinary Tuesday, twenty years from now, that you simply get to keep — never knowing how close you came to losing it. The tools are finally here. Our only job now is the courage to use them early — to stop waiting for the body to break before we're willing to care for it. The future of the heart isn't a better rescue. It's a life that never needed rescuing.

📢 Maintenance Announcement We will undergo a scheduled platform maintenance. Please be informed that during this time, trading services will be temporarily unavailable. 📆 Date: September 5th (Saturday) 🕗 Time: 20:00 ~ 20:45 UTC (Approximately 45 min) We apologize for any inconvenience and appreciate the support.